CD19 and precursor B-cell acute lymphoblastic leukemia: Moreover, as previously discussed, a second downside is that antigen escape, widely accountable for CAR-T cell resistance, has been reported with CD19 CAR as well, in B-ALL [52] and other B cell malignancies [53,54].